1Munoz N. Human papiliomavirus and cancer: the epidemiological evidence[J]. J Clin Virol,2000,19 ( 1 ) :1-4.
2Andersson S, Rylander E, Larsson B, et al. The role of humanpapillomavirus in cervical adenocarcinoma carcinogenesis [J].Eur J Cancer,2001,37 (5) :246-248.
3Elbasha EH, Galvani AP. Vaccination against multiple HPV types[J]. Math Biosci, 2005,197( 1 ) :88-117.
4Choi YD, Jung WW, Nam JH,et al. Detection of HPV genotypes in cervical lesions by the HPV DNA chip and sequencing[ J ]. Gynecol Oncol, 2005,98 ( 3 ) :369-375.
5Parkin DM,Pisani P,Ferlay J,et al.Global cancer statistics[J].CA Cancer J Clin,1999,49(1):31-44.
6Walmboomers JM,Jaclbs MV,Ma nos MM,et al.Human papillomavirus is a necessary cause of invasive cancer worldwide[J].Pathdogy,1993,189(1):12-19.
7Dalstein V,Riethmullet D,Pretet JL,et al.Persistence and load of high-risk HPV are predictors for development of highgrade cervical lesions:a longitudinal French cohort study[J].Iant J Cancer,2003,106(3):396-403.
8Wright TC, Cox LS, Massad LB et al.2003 concensus guidelinea for the manamint of women with cervical cytological abnormalities. JAMA, 2004, 287:2120
9Solomon D, Schilffman M, Tazone R.Comparison of three managemant strategies for patients with atypical squamous cell of undermined significance baseline results from a randomized trial J Natl Cancer Inst, 2004,93:283
10Saslow D, Solomon D. American cancer society guideline fro the early detection of cervical neoplasia and cancer. CA Cancer J Clin. 2004, 48:122
